Skip to main content

Find Clinical Trials

Home
Conditions
Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant

Clinical trial condition

Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant

Explore clinical trials studying Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant trial results

Active, Not Recruiting

Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery

NCT02812420

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hydronephrosis, +30 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details